WELIREG™ (belzutifan) | Official Patient Website
WELIREG is a prescription medicine used to treat adults with kidney cancer that has spread (advanced RCC) following treatment with a PD-1 or PD-L1 and VEGF cancer medicines. It is not known if WELIREG is safe and effective in children.
A Treatment Option for Previously Treated Advanced Kidney
WELIREG is a prescription medicine used to treat adults with kidney cancer that has spread (advanced RCC) following treatment with a PD-1 or PD-L1 and VEGF cancer medicines. It is not known if WELIREG is safe and effective in children.
Taking WELIREG™ (belzutifan)
WELIREG is a prescription medicine used to treat adults with kidney cancer that has spread (advanced RCC) following treatment with a PD-1 or PD-L1 and VEGF cancer medicines. It is not known if WELIREG is safe and effective in children. PD-1 = programmed death receptor-1; PD-L1 = programmed death-ligand 1; VEGF = vascular endothelial growth factor.
Filling a Prescription for WELIREG™ (belzutifan)
WELIREG is a prescription medicine used to treat adults with kidney cancer that has spread (advanced RCC) following treatment with a PD-1 or PD-L1 and VEGF cancer medicines. It is not known if WELIREG is safe and effective in children.
A Treatment Option for Certain von Hippel-Lindau (VHL ... - WELIREG
WELIREG is a prescription medicine used to treat adults with kidney cancer that has spread (advanced RCC) following treatment with a PD-1 or PD-L1 and VEGF cancer medicines. It is not known if WELIREG is safe and effective in children.
What Is von Hippel-Lindau (VHL) Disease? - WELIREG
What is WELIREG? WELIREG is a prescription medicine used to treat adults with von Hippel-Lindau (VHL) disease who need treatment for a type of kidney cancer called renal cell carcinoma (RCC), tumors in the brain and spinal cord called central nervous system (CNS) hemangioblastomas, or a type of pancreatic cancer called pancreatic neuroendocrine ...
How WELIREG™ (belzutifan) Works
WELIREG is a prescription medicine used to treat adults with kidney cancer that has spread (advanced RCC) following treatment with a PD-1 or PD-L1 and VEGF cancer medicines. It is not known if WELIREG is safe and effective in children.
Clinical Trial Results for WELIREG™ (belzutifan)
View clinical trial results with WELIREG™ (belzutifan). See how WELIREG was studied and what was the outcome. Explore clinical trials for both conditions here.
Study Results in Adults with Previously Treated Advanced
WELIREG is a prescription medicine used to treat adults with kidney cancer that has spread (advanced RCC) following treatment with a PD-1 or PD-L1 and VEGF cancer medicines. It is not known if WELIREG is safe and effective in children.
WELIREG is a prescription medicine used to treat adults with kidney cancer that has spread (advanced RCC) following treatment with a PD-1 or PD-L1 and VEGF cancer medicines. It is not known if WELIREG is safe and effective in children.